There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Aurinia Pharmaceuticals Inc (AUPH) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 0.36%, to $8.32. The Aurinia Pharmaceuticals Inc has recorded 23,272 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Aurinia Presents Breadth of Data from AURORA Clinical Program Underscoring Value of LUPKYNISⓇ (voclosporin) for Patients with Lupus Nephritis at ACR 2023.
As a NASDAQ listed company, AUPH falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $8.29 and fluctuated between $8.49 as its day high and $8.21 as its day low. The current market capitalization of Aurinia Pharmaceuticals Inc is $1.19B. A total of 1.23 million shares were traded on the day, compared to an average of 1.75M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, AUPH has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 40 BUYs and 8 SELLs from insiders. Insiders purchased 2,236,316 shares during that period but sold 86,904.
In the most recent transaction, Jayne David R.W. sold 8,733 shares of AUPH for 11.26 per share on May 23. After the transaction, the Director now owns 49,310 company shares. In a previous transaction on May 23, MacKay-Dunn R. Hector sold 4,818 shares at 11.26 per share. AUPH shares that Director owns now total 24,225.
Among the insiders who sold shares, Leversage Jill disposed of 4,815 shares on May 23 at a per-share price of $11.26. This resulted in the Director holding 18,528 shares of AUPH after the transaction. In another insider transaction, Billen Daniel sold 4,650 shares at $11.26 per share on May 23. Company shares held by the Director now total 33,393.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for AUPH in the last 3 months, the mean price target is $13.21 with high estimates of $15.00 and low estimates of $9.50. In terms of 52-week highs and lows, AUPH has a high of $12.43 and a low of $4.07.
As of this writing, AUPH has an earnings estimate of -$0.17 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.13 per share and a lower estimate of -$0.19. The company reported an EPS of -$0.18 in the last quarter, which was 18.20% higher than expectations of -$0.22.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AUPH’s latest balance sheet shows that the firm has $466.08M in Cash & Short Term Investments as of fiscal 2021. There were $8.74M in debt and $40.65M in liabilities at the time. Its Book Value Per Share was $2.73, while its Total Shareholder’s Equity was $479.09M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AUPH is Buy with a score of 4.38.